Inter-allelic recombination in the Plasmodium vivax merozoite surface protein 1 gene among Indian and Colombian isolates by Maestre, Amanda et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
Malaria Journal
Open Access Research
Inter-allelic recombination in the Plasmodium vivax merozoite 
surface protein 1 gene among Indian and Colombian isolates
Amanda Maestre1,2, Sujatha Sunil1,4, Gul Ahmad1, Asif Mohmmed1, 
Marcela Echeverri2, Mauricio Corredor3, Silvia Blair2, Virander S Chauhan1 
and Pawan Malhotra*1
Address: 1International Centre for Genetic Engineering and Biotechnology, New Delhi. India, 2Grupo Malaria, Facultad de Medicina, Universidad 
de Antioquia. Medellin. Colombia, 3Universidad de Pamplona, Corporación para Investigaciones Biológicas, Medellín. Colombia and 4Malaria 
Research Centre, Delhi, India
Email: Amanda Maestre - amaestre@medicina.udea.edu.co; Sujatha Sunil - sujatha13@yahoo.com; Gul Ahmad - gul_ahmad@yahoo.com; 
Asif Mohmmed - amohd@icgeb.res.in; Marcela Echeverri - malaria@quimbaya.udea.edu.co; Mauricio Corredor - mcorredor@cib.org.co; 
Silvia Blair - sblair@catios.udea.edu.co; Virander S Chauhan - virandar@icgeb.res.in; Pawan Malhotra* - pawanm@icgeb.res.in
* Corresponding author    
Abstract
Background: A major concern in malaria vaccine development is the polymorphism observed
among different Plasmodium isolates in different geographical areas across the globe. The merozoite
surface protein 1 (MSP-1) is a leading vaccine candidate antigen against asexual blood stages of
malaria parasite. To date, little is known about the extent of sequence variation in the Plasmodium
vivax MSP-1 gene (Pvmsp-1) among Indian isolates. Since P. vivax accounts for >50% of malaria cases
in India and in Colombia, it is essential to know the Pvmsp-1 gene variability in these two countries
to sustain it as a vaccine candidate. The extent of polymorphism in Pvmsp-1 gene among Indian and
Colombian isolates is described.
Methods: The sequence variation in the region encompassing the inter-species conserved blocks
(ICBs) five and six of Pvmsp-1 gene was examined. PCR was carried out to amplify the polymorphic
region of Pvmsp-1 and the PCR products from twenty (nine Indian and 11 Colombian) isolates were
sequenced and aligned with Belem and Salvador-1 sequences.
Results: Results revealed three distinct types of sequences among these isolates, namely, Salvador-
like, Belem-like and a third type sequence which was generated due to interallelic recombination
between Salvador-like sequences and Belem-like sequences. Existence of the third type in majority
(44%) showed that allelic recombinations play an important role in PvMSP1 diversity in natural
parasite population. Micro-heterogeneity was also seen in a few of these isolates due to nucleotide
substitutions, insertions as well as deletions.
Conclusions: Intergenic recombination in the Pvmsp-1 gene was found and suggest that this is the
main cause for genetic diversity of the Pvmsp-1 gene.
Background
There is an intense global effort to develop an effective
vaccine in addition to the malaria control measures cur-
rently in use. Several vaccine candidate antigens have
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been identified against different stages of the two main
human malaria parasites, Plasmodium falciparum and Plas-
modium vivax, and are being developed as a part of a sub-
unit vaccine [1,2]. One of the major concerns in malaria
vaccine development is the polymorphic nature of the
candidate vaccine antigens. Several in vitro and epidemio-
logical studies have demonstrated that natural variations
can abrogate immune recognition [3,4]. Thus, studies of
sequence and antigenic diversity of malaria vaccine candi-
date antigens become a subject of considerable
importance.
The merozoite surface protein 1 (MSP-1) of Plasmodium
sp. is a large polypeptide of ~200 kDa and is one of the
leading asexual blood stage vaccine candidate antigens
[5]. A number of experimental studies with native and
recombinant MSP-1, particularly its C-terminal frag-
ments, have demonstrated the vaccine potential of MSP-1
[6,7]. Polymorphism has been reported in the P. falci-
parum  MSP-1 (Pfmsp-1) gene among different isolates
across different geographical areas [3]. Based on sequence
variations, the Pfmsp-1  gene has been divided into a
number of blocks that are conserved, semi-conserved and
variable in different species and isolates [5]. Broadly,
Pfmsp-1  gene sequences have been classified into two
allelic families, Wellcome and PNG-MAD 20 type [5,8]. In
addition, intragenic recombinations have been reported
among these two parental alleles, resulting in polymor-
phism among different isolates around the world [9,10].
The gene encoding the merozoite surface protein 1 of P.
vivax (Pvmsp-1) shows many similarities with those from
other malaria species. The gene consists of 10 relatively
conserved blocks alternating with regions of high diversity
[5]. Like the Pfmsp-1 gene, the Pvmsp-1 gene has also been
shown to be dimorphic; identified as Belem, type 1 [11]
and Salvador-1, type 2 [12] forms. In comparison to
Pfmsp-1 polymorphism studies, studies on Pvmsp-1 poly-
morphism are limited. Several regions of Pvmsp-1 have
been amplified and sequenced from field isolates col-
lected from Sri Lanka, Colombia, Brazil, Thailand, Korea
and China [13-18]. A third allele type (type 3) has been
reported among these isolates and it has been suggested
that this allele has arisen due to intragenic recombination
between the Belem and Salvador alleles [18,19]. Recently,
a detailed study of P. vivax merozoite surface protein 1
(Pvmsp-1) gene of 40 isolates from different geographical
areas (Thailand, Brazil, Bangladesh, South Korea, Vanuatu
and Japan) revealed mosaic organization of the Pvmsp-1
gene and heterogeneity in the frequency of allelic recom-
bination among different isolates [16].
The genetic characteristics of P. vivax circulating in distant
endemic regions have not been studied so far. Therefore,
the molecular basis underlying phenomena such as resist-
ance of P. vivax to chloroquine in America and Asia
(20,21) and effective immune responses (which is essen-
tial for vaccine design), have not being fully understood.
Since PvMSP-1 is a potential vaccine candidate for P.
vivax, it is important to further analyse the extent of poly-
morphism from field isolates across the globe. In the
present study, the extent of polymorphism in one of the
variable regions of Pvmsp-1  gene among Indian and
Colombian isolates was investigated. This study is impor-
tant as there is no information of Pvmsp-1 alleles and their
diversity among Indian isolates in spite of P. vivax being
one of the major causes of malaria in India [22].
Subjects and methods
Study area and blood collection
To study the polymorphism in different P. vivax isolates, a
polymorphic region of the MSP-1 between blocks 5–6
corresponding to base pairs 1984–2653 (Belem strain)
was amplified by PCR (Fig. 1). To begin with, venous
blood samples were collected from 50 Colombian and 25
Indian symptomatically infected patients after verbal con-
sent. Colombian isolates were from the malaria clinics of
the northwest region of Colombia (Turbo). Between
1996–2000, this region recorded highest number of
malaria cases with a mean parasite annual index of about
40.  P. vivax accounts for 60% of the total number of
malaria cases (23). Indian isolates were from the north
(Aligarh) and northeast (Nagaland) regions of India,
which are more than 500 km apart. In Aligarh, P. vivax
prevalence is high (60%) while in Nagaland, P. vivax
accounts for 40% of the total number of malaria cases
(24). Blood was either collected into EDTA-containing
vials or spotted onto Whatman-3 filter sheets.
DNA preparation and PCR amplification
P. vivax genomic DNA was isolated from filter discs using
the Chelax extraction procedure [25] and from infected
blood by proteinase K digestion, followed by four rounds
of phenol-chloroform extraction. PCR was carried out to
amplify the polymorphic region of Pvmsp-1 for 30 cycles
of 94°C for one minute 55°C for one minute and 72°C
for two minutes and a final primer extension at 72°C for
five minutes. The forward primer used was 5'-GGGAAT-
TCTACTTGATGGTCCTC-3' (PV1), and the reverse primer
was 5'-GGAATTCTTGTGACATGCGTAAGCG-3' (PV2).
Sequencing, alignment and data analysis
PCR products from twenty (nine Indian and 11 Colom-
bian) isolates were run on a 2% agarose gel and the frag-
ments were purified from gel using a Novagen gel DNA
kit. Gel purified fragments were sequenced in both direc-
tions using an automated DNA sequencer, ABI Prism 310
(Applied Biosystems). Two independent PCR products
were sequenced for each isolate. The deduced amino acid
sequences of the PvMSP-1 from twenty of the isolates areMalaria Journal 2004, 3 http://www.malariajournal.com/content/3/1/4
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shown in figure 2, aligned with the corresponding Belem
and/or Salvador sequences. Based on sequence compari-
son data, the sequences were classified. These DNA
sequences are deposited under GenBank and EMBL Acces-
sion Nos. AY 229861 – AY 229867, AJ 582077-79, AJ
582111-20
Results and discussion
PCR amplification
PCR-amplification revealed size variations (~450 bp and
~520 bp) among these isolates. Size variations were seen
in both Colombian as well as Indian isolates. Among the
Colombian isolates, twenty-nine out of fifty isolates
showed amplification and sixteen out of twenty five
Indian isolates showed amplification. Agarose gel electro-
phoresis revealed a predominance of ~520 bp species
among Indian isolates.
Classification of isolates
Based on sequence comparison data, we classified these
sequences into three basic types: Type 1, Type 2 and Type
3a. This classification was done as previously described by
[15] for the Thai isolates. Type 1 had sequences similar to
the Belem allele, but with a lesser number of Gln residues
in the middle. Isolates CM 12AN, CM 13N, CM 17N and
CM 19N showed 16–18 glutamine residues in compari-
son to Belem allele that had 23 Gln residues. These four
Colombian isolates also showed few other variations as a
result of nucleotide substitutions: All these isolates
showed Val (GTA) at position 742 instead of Asp (GAT)
seen in Belem allele. Likewise isolates CM 13N, CM 17N
and CM 19N had Asp (GAT) for Gly (GGT) at position
810. Similar substitutions had been reported for Thai iso-
lates TD439A, TD424 and TD 425A. In the present study
we did not find Type 1 sequence among Indian isolates.
Type 2 sequences, which are similar to Salvador alleles,
were found among both Indian and Colombian isolates.
These sequences showed slight variations from the Salva-
dor allele. Such variations have been previously reported
for the Thai isolates [15]: a 3 nt insertion encoding Gln
(CAA) and Pro (CCA) was seen in isolates CM 51, CM 70,
IA 14 and IA 6, respectively between Gln 744 and Pro 745
of the Salvador sequence. One such insertion Gln (CAA)
has been previously reported for a Thai isolate T128. In
addition, four non-synonymous nucleotide substitutions
were seen in these Indian as well as Colombian isolates:
CM 51 and IN 8 had a change from Val (GTA)→Ala
(GCA) at position 750, that was also reported in Thai iso-
lates T117, T128 and TD414. Isolates CM 51, CM 19, CM
70, IN 8, IA 6 and IA 14 had Thr (ACT)→Ile (ATT) at posi-
tion 796 as seen among Thai isolates TD 207A and T117.
There was a change from Ala (GCC)→Val (GTC) at posi-
tion 813 in isolates CM 19, IA 6 and IA 14 similar to the
Thai isolate T 117. Likewise, CM 19, IN 1 and IA 14 had a
Schematic representation of the P. vivax msp-1 gene Figure 1
Schematic representation of the P. vivax msp-1 gene. Boxes representing interspecies conserved blocks (ICBs), conserved 
blocks (CBs) and variable blocks are filled, hatched and opened respectively. A scale bar for nucleotide number and relative 
position of primers (Pv1 and Pv2) used for the polymerase chain reaction are indicated at the top and bottom respectively. 
Sequence and location of the primers used for PCR amplification are indicated at the bottom.
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Amino acid sequence alignment of PvMSP-1 polymorphic region between blocks V-VI of twenty field isolates from India and  Colombia with that of Salvador-1 (Sal-1) and Belem isolates Figure 2
Amino acid sequence alignment of PvMSP-1 polymorphic region between blocks V-VI of twenty field isolates from India and 
Colombia with that of Salvador-1 (Sal-1) and Belem isolates. Dots and Dashes represent identical residues and deletions 
respectively.Malaria Journal 2004, 3 http://www.malariajournal.com/content/3/1/4
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Glu (GAG)→Gln (CAG) substitution at position 839,
which had been reported in isolates from other geograph-
ical origins [16].
Type 3a was the third type of sequence seen among these
isolates (Fig. 3). This type of sequence is characterized by
a combination of a Salvador-like sequence at the 5' half of
this region and a Belem-like sequence at the 3' end. Nine
of the twenty isolates (~44%) sequenced showed this type
of recombination. Similar types of recombination have
been reported earlier for Thai, South Korean, Chinese, Sri
Lankan as well as in Colombian isolates (16). The number
of Gln repeats varied between 15 to 18 among these iso-
lates. These sequences were conserved in regions 5' to Gln
repeats. However, two out of nine isolates showed amino
acid changes at two positions in the 3' end (Fig 2). The
presence of a type 3a sequence in more than 40% of the
isolates in the present study indicates that inter-allelic
recombination is one of the main causes for Pvmsp-1 gene
diversity among P. vivax Indian and Colombian
populations.
The main goal of the present study was to determine and
compare the extent of polymorphism in Pvmsp-1 in two
different geographical regions of the world (India and
Colombia). This is important, as data regarding the
sequence variations among P. vivax Indian field isolates is
scanty. A region was selected between the two interspecies
conserved blocks 5 and 6 of Pvmsp-1  for this study.
Though many recombination sites have been identified
within and between the variable blocks of the Pvmsp-1
gene, this region was chosen as it has emerged as an
important genetic marker for P. vivax polymorphism to
detect mixed infection as well as recombination events
between the two parental Salvador and Belem alleles [19].
Results of the present study showed that in both Indian
and Colombian isolates, a similar degree of polymor-
phism for the Pvmsp-1 gene exists and inter-allelic recom-
bination is quite common among these isolates. It is
noteworthy that most of the amino acid changes among
Indian and Colombian isolates match with the changes
seen in other isolates from other geographical areas in par-
ticular, the Thai isolates. Though Belem-like sequence was
not observed among any Indian isolates in the present
study, it may be due to limited sample size. The presence
of the Type 3a sequence among Indian isolates clearly
shows that Belem-like isolates exist among Indian popu-
lation. There are two schools of thought with regards to
Pvmsp-1 polymorphism. Some authors have stated that
intragenic recombination is a rare event in P. vivax and
that is not the main cause for antigenic polymorphism
[26,27]. Other groups argue that recombination is the
main source of antigenic diversity in PvMSP-1
[17,13,15,16]. Another feature of the recombination
events in P. vivax isolates in the present study was that the
recombination took place in a polymorphic segment of
the gene, the polyQ region. This is very much similar to
that reported for other isolates in Asia [16,18]. Thus, the
recombination events in Pvmsp-1  differ from Pfmsp-1
where recombination between MSP-1 alleles occurs in the
conserved segments surrounding the polymorphic
regions whereas in Pvmsp-1, the recombination occurs at
the polymorphic regions [8].
Conclusion
The existence of a large number of Type 3a sequences
among Indian and Colombian isolates generated by the
fusion of Belem and Salvador sequences suggests that
recombination is the main mechanism in Pvmsp-1 allelic
diversity generation among the isolates around the globe.
It is believed that long lasting and recurrent parasitemia
often associated with relapse, a characteristic of P. vivax is
responsible for this high rate of interallelic recombina-
tion. As allelic polymorphism is one of the greatest hur-
dles in mounting a protective immune response against
the genetically diverse P. vivax, further experiments are
required to determine the impact of recombination events
in the immunogenicity of PvMSP-1 antigen in natural
populations.
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